Clinical Trial Update: Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed lot-to-lot consistency and immunogenicity of three lots of GlaxoSmithKline's Hib conjugate vaccine compared with ActHIB and Pentacel in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection

Drugs mentioned

• ACTHIB (Haemophilus influenzae type b conjugate vaccine)
• Hiberix (Haemophilus influenzae type b conjugate vaccine)
• Pentacel (DTaP-Hib-IPV vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b | Phase 3 | Status: COMPLETED | Results posted: 2013-08-19